Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Not enough evidence for thyroid screening, says USPSTF (US Preventive Services Task Force)

This article was originally published in Clinica

Executive Summary

The US Preventive Services Task Force has found insufficient clinical evidence to recommend for or against routine screening for thyroid disease in adults. Although there is "fair evidence" to suggest that the thyroid stimulating hormone test can detect subclinical thyroid disease in people without symptoms, there is only "poor evidence" to suggest that treatment will help adults identified in this way, the group concluded. Moreover, it warned there is a potential for harm caused by false positive tests, given the potential adverse effects of antithyroid drugs, radioiodine, thyroid surgery and thyroid replacement therapy if detection and early treatment is unnecessary.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT057180

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel